Reimbursement policies and healthcare plans are a complicated business and few healthcare professionals have the time or the resources to stay on top of the latest changes. At Aerocrine, we monitor national changes and help our clients understand how these may affect the way they deliver healthcare services.
- Aerocrine can provide data from health economic analysis of using our products like NIOX or NIOX MINO as well as provide recently published health economic abstracts and articles.
- Aerocrine can provide a list of most relevant publications to support reimbursement dossiers. If you’re interested in reading more about the health economic advantage of FENO measuring, please take a look at these key references.
- Resource management
Aerocrine is committed to giving healthcare professionals the information needed to secure the highest level of payment and reimbursement for FENO monitoring. We can also show how using NIOX MINO to monitor FENO reduces overall costs, taking into account healthcare expenditures. A better understanding of where and how money is spent will lead to overall better allocation of limited resources.
- Cost-effectiveness studies comparing different monitoring tools
Aerocrine can assist in getting the most out of cost-effectiveness studies using NIOX or NIOX MINO by helping identify the outcome variables specific to your region or setting. We can also provide assistance with study design.
- Country-specific reimbursement codes
Aerocrine can provide the specific reimbursement codes used in Europe, North America, Africa and Asia.
- Budget Impact Calculator
At Aerocrine, we’ve developed an economic model called a Budget Impact Calculator (BIC) to assist healthcare professionals calculate how much money can be saved when asthma management incorporates FENO testing with NIOX or NIOX MINO.
The Budget Impact Calculator will be available by the end of May 2008